
About Prof Heard

He trained in clinical neurophysiology at Westmead Hospital. He was appointed staff specialist at Royal Prince Alfred Hospital, Sydney. He founded the Westmead MS clinic where he was a member of a genetics research team which identified the first new MS susceptibility gene in more than 30 years and which has published widely, including papers in Nature, Nature Genetics, Lancet Neurology, J Immunology and NEJM. He has participated in several clinical trials and was inaugural Chairman of the MSRA Clinical Trials Network. He is a Committee Member of ANZAN Asia Pacific. He is a Fellow of the American Academy of Neurology, a Fellow and Australian Advisory Member for the Royal College of Physicians (UK) and has examined for the Royal Australasian College of Physicians. He is currently a conjoint professor in the University of Newcastle.
